Dr. Noon Fundus
Glaucoma, cataract, and retinal disease diagnosis
Regulatory ApprovedCommercial
Key Facts
Indication
Glaucoma, cataract, and retinal disease diagnosis
Phase
Regulatory Approved
Status
Commercial
Company
About Mediwhale
AI‑powered retinal imaging platform for early cardiometabolic disease risk assessment and eye‑disease diagnosis.
View full company profile